PL3535388T3 - Sposoby oczyszczania wirusów związanych z adenowirusami - Google Patents

Sposoby oczyszczania wirusów związanych z adenowirusami

Info

Publication number
PL3535388T3
PL3535388T3 PL17866365.4T PL17866365T PL3535388T3 PL 3535388 T3 PL3535388 T3 PL 3535388T3 PL 17866365 T PL17866365 T PL 17866365T PL 3535388 T3 PL3535388 T3 PL 3535388T3
Authority
PL
Poland
Prior art keywords
adeno
associated virus
purification methods
virus purification
methods
Prior art date
Application number
PL17866365.4T
Other languages
English (en)
Inventor
Christian Fiedler
Leopold Grillberger
Meinhard Hasslacher
Barbara Kraus
Dominik MITTERGRADNEGGER
Stefan REUBERGER
Horst Schafhauser
Marian BENDIK
Original Assignee
Takeda Pharmaceutical Company Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical Company Limited filed Critical Takeda Pharmaceutical Company Limited
Publication of PL3535388T3 publication Critical patent/PL3535388T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/76Viruses; Subviral particles; Bacteriophages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/76Viruses; Subviral particles; Bacteriophages
    • A61K35/761Adenovirus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011Details
    • C12N2750/14011Parvoviridae
    • C12N2750/14111Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14133Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011Details
    • C12N2750/14011Parvoviridae
    • C12N2750/14111Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011Details
    • C12N2750/14011Parvoviridae
    • C12N2750/14111Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14151Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
PL17866365.4T 2016-11-04 2017-11-03 Sposoby oczyszczania wirusów związanych z adenowirusami PL3535388T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662417775P 2016-11-04 2016-11-04
PCT/US2017/059967 WO2018128688A1 (en) 2016-11-04 2017-11-03 Adeno-associated virus purification methods

Publications (1)

Publication Number Publication Date
PL3535388T3 true PL3535388T3 (pl) 2023-08-14

Family

ID=62044944

Family Applications (1)

Application Number Title Priority Date Filing Date
PL17866365.4T PL3535388T3 (pl) 2016-11-04 2017-11-03 Sposoby oczyszczania wirusów związanych z adenowirusami

Country Status (15)

Country Link
US (2) US11000561B2 (pl)
EP (2) EP4234688A3 (pl)
JP (1) JP7071348B2 (pl)
KR (1) KR102482744B1 (pl)
CN (1) CN110168081B (pl)
AU (1) AU2017391164B2 (pl)
CA (1) CA3040288A1 (pl)
ES (1) ES2948849T3 (pl)
FI (1) FI3535388T3 (pl)
IL (1) IL266162B2 (pl)
MX (1) MX2019004784A (pl)
PL (1) PL3535388T3 (pl)
PT (1) PT3535388T (pl)
SG (1) SG11201903890QA (pl)
WO (1) WO2018128688A1 (pl)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110225975A (zh) 2016-08-23 2019-09-10 阿库斯股份有限公司 用于治疗人受试者中非年龄相关的听力损害的组合物和方法
CA3104196A1 (en) * 2018-07-11 2020-01-16 Baxalta Incorporated Aav compositions
US20210082541A1 (en) * 2019-08-31 2021-03-18 Wyatt Technology Corporation Measuring attributes of a viral gene delivery vehicle sample via separation
EP4073083A1 (en) * 2019-12-12 2022-10-19 EMD Millipore Corporation Intensified virus filtration using diafiltration buffer
JP7588466B2 (ja) * 2020-01-22 2024-11-22 旭化成メディカル株式会社 パルボウイルスの生産方法
WO2021153659A1 (ja) * 2020-01-31 2021-08-05 Agc株式会社 アデノ随伴ウイルス(aav)の定量方法
EP3868886A1 (en) * 2020-02-21 2021-08-25 Bia Separations D.O.O. A method for separation or depletion of empty aav capsids from full aav capsids
IL295747A (en) 2020-02-21 2022-10-01 Akouos Inc Preparations and methods for the treatment of hearing impairment that is not related to age in humans
CN116261483B (zh) * 2020-08-18 2026-01-27 赛多利斯比亚分离有限责任公司 多模式金属亲和加工衣壳
CN111808828B (zh) * 2020-09-14 2020-11-17 和元生物技术(上海)股份有限公司 腺相关病毒的分离纯化方法
CA3195637A1 (en) * 2020-10-14 2022-04-21 Arvind Srivastava Membrane rupture compositions and methods of making and using same
WO2022094461A1 (en) * 2020-11-02 2022-05-05 Biomarin Pharmaceutical Inc. Process for enriching adeno-associated virus
US20220169991A1 (en) * 2020-12-01 2022-06-02 Global Life Sciences Solutions Usa Llc Viral vector purification apparatus and method
WO2022220273A1 (ja) 2021-04-15 2022-10-20 国立大学法人東京大学 ウイルス粒子の製造方法
US20240390517A1 (en) 2021-04-30 2024-11-28 Takeda Pharmaceutical Company Limited Aav8 capsid variants with enhanced liver targeting
WO2022229703A2 (en) 2021-04-30 2022-11-03 Takeda Pharmaceutical Company, Ltd. New aav8 based immune escaping variants
WO2023028035A1 (en) * 2021-08-23 2023-03-02 University Of Florida Research Foundation, Incorporated Lipid enveloped recombinant aav particles for gene therapy use
GB202206123D0 (en) * 2022-04-27 2022-06-08 Cytiva Bioprocess R & D Ab A pre-screening method and a method for separating adeno-associated virus capsids

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4158054A (en) 1973-10-18 1979-06-12 Duncan Flockhart & Co. Ltd. Preparation of virus sub-unit vaccines
JPS5415417A (en) 1977-06-10 1979-02-05 Hitachi Ltd Fabrication of cast
ATE1882T1 (de) 1978-05-08 1982-12-15 Merck & Co. Inc. Ein verfahren zur direkten extraktion von kleinen teilchen bis 50 nm aus einer proteinhaltigen fluessigkeit.
US4217418A (en) 1978-05-08 1980-08-12 Merck & Co., Inc. Recovery of small particles by flow centrifugation
JPH06247995A (ja) 1991-06-24 1994-09-06 Asahi Chem Ind Co Ltd 新規なシアリル(α2−6)ラクトテトラオシルセラミド
US5688675A (en) * 1995-06-07 1997-11-18 Research Foundation Of State University Of New York In vitro packaging of adeno-associated virus DNA
WO1999061643A1 (en) * 1998-05-27 1999-12-02 University Of Florida Method of preparing recombinant adeno-associated virus compositions by using an iodixananol gradient
EP1104767A1 (en) * 1999-11-30 2001-06-06 Stichting Dienst Landbouwkundig Onderzoek Mono- and disaccharide derivatives containing both fatty acid ester and sulfate ester groups
AU3847801A (en) 2000-02-15 2001-08-27 Intellivax International Inc Proteosome influenza vaccine
AU2002348151A1 (en) * 2001-11-05 2003-05-19 Genvec, Inc. Viral vector production methods and compositions
AU2003229060A1 (en) * 2002-05-14 2003-12-02 Merck And Co., Inc. Methods of adenovirus purification
EP1608683B1 (en) 2003-04-01 2011-11-23 Institut National De La Sante Et De La Recherche Medicale (Inserm) Antibodies directed against hepatitis c virus e1e2 complex and pharmaceutical compositions
PT2277996E (pt) 2003-05-21 2014-12-16 Genzyme Corp Métodos para produzir preparações de vírions de aav recombinantes substancialmente livres de capsídeos vazios
JP2007068401A (ja) 2003-08-07 2007-03-22 Chemo Sero Therapeut Res Inst 西ナイルウイルスワクチン
CN1739801A (zh) 2004-08-27 2006-03-01 上海生物制品研究所 一种流行性感冒病毒裂解疫苗及其制备方法
JP5745717B2 (ja) 2007-05-04 2015-07-08 バクスター・インターナショナル・インコーポレイテッドBaxter International Incorp0Rated ウイルス精製のための連続超遠心分離用の糖溶液の処方
HUE028341T2 (en) * 2009-06-16 2016-12-28 Genzyme Corp Improved methods for purification of recombinant aav vectors
SI2459702T1 (sl) * 2009-07-31 2016-11-30 Baxalta GmbH Gojišče celične kulture za izražanje adamts proteina
WO2011094198A1 (en) 2010-01-28 2011-08-04 The Children's Hospital Of Philadelphia Research Institute, Abramson Research Center A scalable manufacturing platform for viral vector purification and viral vectors so purified for use in gene therapy
WO2011097447A2 (en) * 2010-02-04 2011-08-11 Neurologix, Inc. Production of recombinant virus
CA2905952A1 (en) * 2013-03-13 2014-10-02 The Children's Hospital Of Philadelphia Adeno-associated virus vectors and methods of use thereof
EP3054007A1 (en) 2015-02-09 2016-08-10 Institut National De La Sante Et De La Recherche Medicale (Inserm) Recombinant adeno-associated virus particle purification comprising an immuno-affinity purification step
EP3054006A1 (en) * 2015-02-09 2016-08-10 Institut National De La Sante Et De La Recherche Medicale (Inserm) Recombinant adeno-associated virus particle purification with multiple-step anion exchange chromatography
CN105396128A (zh) * 2015-11-11 2016-03-16 北京科兴中维生物技术有限公司 一种纯化脊髓灰质炎病毒液的方法

Also Published As

Publication number Publication date
PT3535388T (pt) 2023-06-27
AU2017391164B2 (en) 2024-01-04
BR112019009033A2 (pt) 2019-07-09
CN110168081B (zh) 2024-08-16
KR102482744B1 (ko) 2022-12-30
US20190365835A1 (en) 2019-12-05
EP4234688A2 (en) 2023-08-30
RU2019113381A (ru) 2020-12-04
US20210338752A1 (en) 2021-11-04
EP4234688A3 (en) 2023-09-27
EP3535388B1 (en) 2023-05-31
CN110168081A (zh) 2019-08-23
IL266162B1 (en) 2023-07-01
ES2948849T3 (es) 2023-09-20
IL266162A (en) 2019-06-30
NZ752623A (en) 2025-09-26
MX2019004784A (es) 2019-08-12
AU2017391164A1 (en) 2019-05-02
EP3535388A1 (en) 2019-09-11
KR20190073529A (ko) 2019-06-26
JP2020502997A (ja) 2020-01-30
SG11201903890QA (en) 2019-05-30
US12246047B2 (en) 2025-03-11
IL266162B2 (en) 2023-11-01
JP7071348B2 (ja) 2022-05-18
WO2018128688A1 (en) 2018-07-12
US11000561B2 (en) 2021-05-11
FI3535388T3 (fi) 2023-06-14
CA3040288A1 (en) 2018-07-12
RU2019113381A3 (pl) 2021-04-06

Similar Documents

Publication Publication Date Title
IL275533A (en) Adeno-associated virus purification methods
IL266162A (en) Adeno-associated virus purification methods
IL279154B (en) Adenovirus-related vector
IL266264A (en) Adeno-associated virus formulations
ZA201804735B (en) Chromatography based purification strategies for viruses
EP3393508C0 (en) ZIKA VIRUS PURIFICATION PROCESS
GB201401707D0 (en) Adeno-associated viral vectors
EP3273020A4 (en) Discharged-gas purification device
GB201406608D0 (en) Virus
IL261040B (en) Protein purification
GB201512898D0 (en) Abatement system
GB201419572D0 (en) Virus
GB2545964B (en) Priority-based decoding
TWI562818B (en) Purifying system
GB201509609D0 (en) Cleaning system
HK40038494A (en) Adeno-associated virus purification methods
GB201522013D0 (en) Virus
GB201600380D0 (en) Modified virus
GB201516936D0 (en) Virus
GB201507419D0 (en) Virus
ZA201704191B (en) Petrol - ethanol mixtures
GB201406470D0 (en) Virus
GB201403582D0 (en) Virus
GB201512901D0 (en) Abatement system
GB201519916D0 (en) Desalination arrangement